New study suggests opportunities in Indian hypothyroidism market
This article was originally published in Scrip
Executive Summary
Large multinational firms are continuing to engage with multiple stakeholders in India as part of their efforts to raise disease awareness and diagnosis and potentially to expand both access to medicines and the market for their products in the country.